61 related articles for article (PubMed ID: 20819644)
21. Arsenic trioxide inhibits proliferation and induces apoptosis in pancreatic cancer cells.
Li X; Ding X; Adrian TE
Anticancer Res; 2002; 22(4):2205-13. PubMed ID: 12174905
[TBL] [Abstract][Full Text] [Related]
22. Apoptosis induced by adenovirus-mediated p14ARF expression in U2OS osteosarcoma cells is associated with increased Fas expression.
Kim M; Sgagias M; Deng X; Jung YJ; Rikiyama T; Lee K; Ouellette M; Cowan K
Biochem Biophys Res Commun; 2004 Jul; 320(1):138-44. PubMed ID: 15207713
[TBL] [Abstract][Full Text] [Related]
23. Up-regulation of telomere-binding TRF1, TRF2 related to reactive oxygen species induced by As(2)O(3) in MGC-803 cells.
Zhang Y; Cao EH; Qin JF
Eur J Pharmacol; 2005 May; 516(1):1-9. PubMed ID: 15904916
[TBL] [Abstract][Full Text] [Related]
24. Interleukin-12 up-regulates Fas expression in human osteosarcoma and Ewing's sarcoma cells by enhancing its promoter activity.
Zhou Z; Lafleur EA; Koshkina NV; Worth LL; Lester MS; Kleinerman ES
Mol Cancer Res; 2005 Dec; 3(12):685-91. PubMed ID: 16380506
[TBL] [Abstract][Full Text] [Related]
25. Curcumin induces cell cycle arrest and apoptosis in human osteosarcoma (HOS) cells.
Lee DS; Lee MK; Kim JH
Anticancer Res; 2009 Dec; 29(12):5039-44. PubMed ID: 20044614
[TBL] [Abstract][Full Text] [Related]
26. Increased cure rate of glioblastoma using concurrent therapy with radiotherapy and arsenic trioxide.
Ning S; Knox SJ
Int J Radiat Oncol Biol Phys; 2004 Sep; 60(1):197-203. PubMed ID: 15337556
[TBL] [Abstract][Full Text] [Related]
27. Effect of arsenic trioxide (ATO) on human lung carcinoma PG cell line: ATO induced apoptosis of PG cells and decreased expression of Bcl-2, Pgp.
Han B; Zhou G; Zhang Q; Zhang J; Wang X; Tang W; Kakudo K
J Exp Ther Oncol; 2004 Dec; 4(4):335-42. PubMed ID: 15844663
[TBL] [Abstract][Full Text] [Related]
28. Interleukin (IL)-12 and IL-12 gene transfer up-regulate Fas expression in human osteosarcoma and breast cancer cells.
Lafleur EA; Jia SF; Worth LL; Zhou Z; Owen-Schaub LB; Kleinerman ES
Cancer Res; 2001 May; 61(10):4066-71. PubMed ID: 11358827
[TBL] [Abstract][Full Text] [Related]
29. Arsenic trioxide suppresses thymidylate synthase in 5-FU-resistant colorectal cancer cell line HT29 In Vitro re-sensitizing cells to 5-FU.
Subbarayan PR; Lee K; Ardalan B
Anticancer Res; 2010 Apr; 30(4):1157-62. PubMed ID: 20530422
[TBL] [Abstract][Full Text] [Related]
30. Effects of Survivin on cell proliferation and apoptosis in MG-63 cells in vitro.
Liang X; Da M; Zhuang Z; Wu W; Wu Z; Wu Y; Shen H
Cell Biol Int; 2009 Jan; 33(1):119-24. PubMed ID: 18996209
[TBL] [Abstract][Full Text] [Related]
31. Stathmin is key in reversion of doxorubicin resistance by arsenic trioxide in osteosarcoma cells.
Feng T; Qiao G; Feng L; Qi W; Huang Y; Yao Y; Shen Z
Mol Med Rep; 2014 Dec; 10(6):2985-92. PubMed ID: 25310700
[TBL] [Abstract][Full Text] [Related]
32. [Selective inducement effect of bacterial redox protein azurin on apoptosis of human osteosarcoma cell line U2OS].
Ye ZM; Miao XD; Yang DS; Xu RZ; Huang X; Ge FF
Ai Zheng; 2005 Mar; 24(3):298-304. PubMed ID: 15757530
[TBL] [Abstract][Full Text] [Related]
33. Arsenic trioxide induces apoptosis of p53 null osteosarcoma MG63 cells through the inhibition of catalase.
Wang Y; Wei Y; Zhang H; Shi Y; Li Y; Li R
Med Oncol; 2012 Jun; 29(2):1328-34. PubMed ID: 21308489
[TBL] [Abstract][Full Text] [Related]
34. Using targeted magnetic arsenic trioxide nanoparticles for osteosarcoma treatment.
Li XS; Li WQ; Wang WB
Cancer Biother Radiopharm; 2007 Dec; 22(6):772-8. PubMed ID: 18158768
[TBL] [Abstract][Full Text] [Related]
35. Evaluation of quercetin as a potential drug in osteosarcoma treatment.
Berndt K; Campanile C; Muff R; Strehler E; Born W; Fuchs B
Anticancer Res; 2013 Apr; 33(4):1297-306. PubMed ID: 23564766
[TBL] [Abstract][Full Text] [Related]
36. Arsenic trioxide prevents osteosarcoma growth by inhibition of GLI transcription via DNA damage accumulation.
Nakamura S; Nagano S; Nagao H; Ishidou Y; Yokouchi M; Abematsu M; Yamamoto T; Komiya S; Setoguchi T
PLoS One; 2013; 8(7):e69466. PubMed ID: 23861973
[TBL] [Abstract][Full Text] [Related]
37. Inhibition of osteosarcoma cell proliferation by the Hedgehog-inhibitor cyclopamine.
Warzecha J; Göttig S; Chow KU; Brüning C; Percic D; Boehrer S; Brude E; Kurth A
J Chemother; 2007 Oct; 19(5):554-61. PubMed ID: 18073155
[TBL] [Abstract][Full Text] [Related]
38. Enhancement of osteosarcoma cell sensitivity to cisplatin using paclitaxel in the presence of hyperthermia.
Huang T; Gong W; Li X; Zou C; Jiang G; Li X; Feng D
Int J Hyperthermia; 2013 May; 29(3):248-55. PubMed ID: 23527624
[TBL] [Abstract][Full Text] [Related]
39. Combination of Hedgehog inhibitors and standard anticancer agents synergistically prevent osteosarcoma growth.
Saitoh Y; Setoguchi T; Nagata M; Tsuru A; Nakamura S; Nagano S; Ishidou Y; Nagao-Kitamoto H; Yokouchi M; Maeda S; Tanimoto A; Furukawa T; Komiya S
Int J Oncol; 2016 Jan; 48(1):235-42. PubMed ID: 26548578
[TBL] [Abstract][Full Text] [Related]
40. Synergistic anti-tumor effects of arsenic trioxide and blue LED irradiation on human osteosarcoma.
Feng C; Gong R; Zheng Q; Yan G; He M; Lei H; Li X; Zhang L; Xu Z; Liu S; Yu M; Ma T; Gao M; Bamba D; Idiiatullina E; Zagidullin N; Pavlov V; Xu C; Yuan Y; Yang L
Int J Biol Sci; 2019; 15(2):386-394. PubMed ID: 30745828
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]